| RLEs | 13 | May 16, 2013 |
| DIT immunology | 23 | May 15, 2013 |
| thyroid drugs | 10 | April 15, 2013 |
| pituitary | 16 | April 15, 2013 |
| consciousness | 16 | April 9, 2013 |
| ANS | 22 | April 9, 2013 |
| cortical pathology | 14 | April 8, 2013 |
| tauopathies & synucleinopathies | 11 | April 8, 2013 |
| limbic system | 10 | April 8, 2013 |
| hypothalamus | 22 | April 5, 2013 |
| drugs of abuse | 13 | March 25, 2013 |
| neurodegenerative drugs | 17 | March 25, 2013 |
| general anesthetics | 25 | March 25, 2013 |
| anxiety & sedation | 18 | March 25, 2013 |
| antiepileptics | 17 | March 24, 2013 |
| antipsychotics | 13 | March 24, 2013 |
| antidepressants | 27 | March 24, 2013 |
| local anestehtics | 17 | March 24, 2013 |
| analgesics | 28 | March 18, 2013 |
| antianginals | 14 | February 23, 2013 |
| cholesterol & lipid drugs | 20 | February 23, 2013 |
| anticoagulants | 24 | February 23, 2013 |
| antiarrhythmic drugs | 29 | February 23, 2013 |
| heart failure | 29 | February 22, 2013 |
| ANS | 30 | February 22, 2013 |
| renal | 27 | February 20, 2013 |
| sensory pathways | 8 | February 17, 2013 |
| common peripheral neve injury | 11 | February 17, 2013 |
| cord syndromes | 11 | February 16, 2013 |
| tone & reflexes | 15 | February 16, 2013 |
| sensory receptor modalities | 8 | February 16, 2013 |
| descending motor pathways | 12 | February 15, 2013 |
| pain & temp modalities | 6 | February 15, 2013 |
| demyelinating pathophys | 10 | February 14, 2013 |
| cell death | 13 | February 14, 2013 |
| antineoplastics II | 20 | February 2, 2013 |
| antineoplastics | 33 | February 2, 2013 |
| antiretrovirals | 9 | February 2, 2013 |
| antiparasitics | 32 | February 1, 2013 |
| antivirals | 9 | January 29, 2013 |
| antifungals | 12 | January 28, 2013 |
| antimycobacterials | 8 | January 28, 2013 |
| protein synth inhibitors | 26 | January 28, 2013 |
| cell wall inhibitors | 19 | January 24, 2013 |
| metabolic & DNA synth inhibitors | 15 | January 24, 2013 |
| electrical properties of neurons | 10 | January 19, 2013 |
| synapses | 28 | January 17, 2013 |
| pharmacogenomics | 16 | January 13, 2013 |
| toxicology | 11 | January 13, 2013 |
| pharmacokinetics | 17 | January 13, 2013 |
| urinary neoplasia | 6 | December 5, 2012 |
| lower urinary | 7 | December 5, 2012 |
| vascular dz of kidney | 9 | December 5, 2012 |
| parasitic diseases & symptoms | 22 | December 2, 2012 |
| parasitology overview | 7 | November 30, 2012 |
| parasitology | 39 | November 29, 2012 |
| subcutaneous and other mycoses | 13 | November 28, 2012 |
| opportunistic mycoses | 26 | November 28, 2012 |
| systemic mycoses | 11 | November 27, 2012 |
| fungal-lab dx & dermatophytes | 15 | November 27, 2012 |
| mycology I | 12 | November 27, 2012 |
| glomerulopathies assc w/ systemic dz | 5 | November 27, 2012 |
| tubulointerstitial diseases | 7 | November 27, 2012 |
| 1˚ glomerulopathies | 11 | November 26, 2012 |
| congenital renal & overview | 16 | November 26, 2012 |
| markers | 16 | November 17, 2012 |
| gestation & placental disorders | 14 | November 16, 2012 |
| diseases of infancy & childhood | 20 | November 16, 2012 |
| joints | 10 | November 15, 2012 |
| bone & cartilage | 19 | November 15, 2012 |
| ovary & tube | 20 | November 15, 2012 |
| spleen & thymus | 9 | November 15, 2012 |
| myeloid neoplasms | 25 | November 15, 2012 |
| peripheral T & Hodgkin's | 13 | November 14, 2012 |
| peripheral B cell neoplasms | 21 | November 14, 2012 |
| precursor lymphoid neoplasia | 14 | November 14, 2012 |
| uterus | 13 | November 14, 2012 |
| vulva, vagina, & cervix | 14 | November 13, 2012 |
| infertility | 12 | November 13, 2012 |
| reproductive pathology | 14 | November 13, 2012 |
| arbovirus | 7 | November 2, 2012 |
| ortho & paramysoviruses | 13 | November 2, 2012 |
| retroviruses | 10 | November 2, 2012 |
| picorna & coronavirus | 16 | November 2, 2012 |
| rota & norovirus | 10 | November 1, 2012 |
| rubella & rhabdo | 17 | November 1, 2012 |
| hepatits | 14 | November 1, 2012 |
| herpes | 27 | October 31, 2012 |
| pox, parvo, prion | 15 | October 31, 2012 |
| HPV, polyoma, adeno | 7 | October 31, 2012 |
| virus immunology | 13 | October 30, 2012 |
| viral replication | 10 | October 30, 2012 |
| virus intro | 7 | October 30, 2012 |
| chlamydia & rickettsia | 16 | October 29, 2012 |
| mycobacteria | 12 | October 29, 2012 |
| genetics | 22 | October 25, 2012 |
| breast pathology | 16 | October 25, 2012 |
| diabetes | 5 | October 25, 2012 |
| biliary | 17 | October 22, 2012 |
| hepatic neoplasia | 13 | October 22, 2012 |
| toxic, metabolic, circulatory liver | 22 | October 22, 2012 |
| hepatitis | 21 | October 22, 2012 |
| nutrition | 17 | October 22, 2012 |
| liver pathophys | 22 | October 22, 2012 |
| peds GI | 18 | October 21, 2012 |
| small & large bowel | 29 | October 21, 2012 |
| stomach & pancreas | 19 | October 21, 2012 |
| upper GI | 20 | October 21, 2012 |
| bacterial morphology | 24 | October 7, 2012 |
| G neg rods | 28 | October 6, 2012 |
| G+ rods | 5 | October 6, 2012 |
| pyogenic | 10 | October 6, 2012 |
| treatment of bugs | 31 | October 5, 2012 |
| anaerobes | 10 | October 5, 2012 |
| antibiotics | 33 | October 3, 2012 |
| bacterial toxins | 16 | September 30, 2012 |
| pediatric pulmonary disease | 14 | September 29, 2012 |
| diseases of the pleura & pericardium | 8 | September 29, 2012 |
| pulmonary neoplasia | 13 | September 29, 2012 |
| pulmonary infections | 15 | September 29, 2012 |
| pulmonary vascular disease | 13 | September 28, 2012 |
| COPD | 9 | September 28, 2012 |
| pulmonary parenchymal disease | 17 | September 28, 2012 |
| congenital heart disease | 9 | September 28, 2012 |
| upper respiratory | 10 | September 27, 2012 |
| bacterial genetics | 26 | September 27, 2012 |
| bacterial growth & nutrition | 11 | September 27, 2012 |
| bacterial structure | 17 | September 27, 2012 |
| congestive heart failure | 8 | September 24, 2012 |
| systemic hypertension | 6 | September 24, 2012 |
| valvular heart disease | 7 | September 24, 2012 |
| cardiomyopathies | 15 | September 20, 2012 |
| ischemic heart disease | 13 | September 20, 2012 |
| disinfection | 19 | September 17, 2012 |
| endocrine pathology | 34 | September 12, 2012 |
| soft tissue tumors | 8 | September 12, 2012 |
| dermopathology | 24 | September 12, 2012 |
| autoimmunity | 15 | September 11, 2012 |
| WBC abnormalities | 20 | September 11, 2012 |
| tumor markers | 23 | September 11, 2012 |
| anemias | 17 | September 10, 2012 |
| red cell morphology | 15 | September 10, 2012 |
| intro neoplasia | 20 | September 10, 2012 |
| immunodeficiencies | 15 | September 9, 2012 |
| vaccines | 18 | September 6, 2012 |
| tolerance & autoimmunity | 19 | September 4, 2012 |
| humoral immunity | 19 | September 3, 2012 |
| effectors of cell-mediated defense | 7 | September 2, 2012 |
| generation of cell-mediated immunity | 9 | August 30, 2012 |
| Ag recognition | 13 | August 30, 2012 |
| Ag capture & presentation | 10 | August 29, 2012 |
| surgical pathology | 7 | August 23, 2012 |
| tissue inflammation & repair | 13 | August 22, 2012 |
| bleeding disorders | 15 | August 20, 2012 |
| hemostasis & thrombosis | 19 | August 19, 2012 |
| cell injury & adaptation | 9 | August 17, 2012 |
| mechanisms of infectious disease | 17 | August 16, 2012 |
| complement system | 9 | August 16, 2012 |
| innate immunity | 13 | August 16, 2012 |
| vascular pathology | 31 | August 14, 2012 |
| female reproductive physiology | 27 | April 25, 2012 |
| male reproductive | 8 | April 24, 2012 |
| adrenal physiology | 24 | April 24, 2012 |
| calcium regulation | 10 | April 21, 2012 |
| thyroid hormone physiology | 10 | April 21, 2012 |
| endocrine control of growth | 12 | April 21, 2012 |
| pancreatic islet hormones | 23 | April 20, 2012 |
| fuel metabolism | 11 | April 19, 2012 |
| pituitary gland control | 9 | April 19, 2012 |
| bile & metabolism | 8 | April 18, 2012 |
| lipid & vitamin digestion | 10 | April 18, 2012 |
| hepatobiliary | 8 | April 18, 2012 |
| GI electrolyte & water transport | 10 | April 18, 2012 |
| carb & protein digestion | 12 | April 18, 2012 |
| GI secretion | 21 | April 17, 2012 |
| GI motility | 10 | April 17, 2012 |
| GI organization | 26 | April 17, 2012 |
| lymphoid | 14 | April 7, 2012 |
| endocrine | 21 | April 5, 2012 |
| female reproductive | 14 | April 4, 2012 |
| male reproductive | 17 | April 4, 2012 |
| urinary | 22 | April 3, 2012 |
| alimentary canal | 28 | April 3, 2012 |
| pancreas | 7 | April 3, 2012 |
| oral cavity | 14 | April 2, 2012 |
| acid/base balance | 14 | March 28, 2012 |
| renal regulation of BP | 6 | March 28, 2012 |
| regulation of ECV | 13 | March 28, 2012 |
| regulation of K, Mg, Ca, phosphate | 10 | March 28, 2012 |
| urine concentration | 10 | March 28, 2012 |
| renal transport | 18 | March 28, 2012 |
| plasma clearance | 11 | March 28, 2012 |
| gas transport in blood | 6 | March 27, 2012 |
| limitations in gas exchange | 11 | March 27, 2012 |
| gas exchange | 11 | March 27, 2012 |
| distribution of perfusion | 9 | March 27, 2012 |
| distribution of ventilation | 6 | March 27, 2012 |
| control of ventilation | 19 | March 26, 2012 |
| airway resistance | 7 | March 26, 2012 |
| mechanisms of respiration | 11 | March 26, 2012 |
| organization of respiratory | 8 | March 26, 2012 |
| liver & gall bladder | 26 | March 21, 2012 |
| respiratory | 28 | March 20, 2012 |
| dynamic respiratory mechanics | 12 | March 18, 2012 |
| immune response | 23 | March 7, 2012 |
| integument | 30 | March 6, 2012 |
| epithelia | 25 | February 25, 2012 |
| eye | 38 | February 25, 2012 |
| integrated CV responses | 13 | February 23, 2012 |
| special circulations | 16 | February 23, 2012 |
| hearing | 23 | February 22, 2012 |
| coronary arteries | 9 | February 21, 2012 |
| blood pressure regulation | 10 | February 21, 2012 |
| cardiac output | 16 | February 21, 2012 |
| regulation of stroke volume | 10 | February 21, 2012 |
| heart mechanics | 12 | February 20, 2012 |
| microcirculation | 15 | February 20, 2012 |
| smooth muscle | 10 | February 20, 2012 |
| peripheral circulation | 9 | February 20, 2012 |
| CV | 27 | February 16, 2012 |
| muscle | 22 | February 15, 2012 |
| hematopoiesis | 18 | February 7, 2012 |
| blood | 20 | February 7, 2012 |
| bone | 22 | February 7, 2012 |
| connective tissue | 17 | February 7, 2012 |
| hemodynamics | 15 | February 3, 2012 |
| muscle | 23 | January 25, 2012 |
| arrhythmias | 12 | January 24, 2012 |
| electrophysiology | 16 | January 24, 2012 |
| cardiac muscle | 18 | January 24, 2012 |
| signal transduction | 20 | January 24, 2012 |
| synaptic transmission | 22 | January 24, 2012 |
| cell motility | 31 | January 22, 2012 |
| membranes & membrane proteins | 19 | January 20, 2012 |
| cell cycle | 13 | January 19, 2012 |
| cell signaling | 20 | January 19, 2012 |
| organelles II | 18 | January 19, 2012 |
| membrane & action potential | 13 | January 16, 2012 |
| membrane transport | 15 | January 16, 2012 |
| internal environment | 16 | January 16, 2012 |
| biological barriers & compartments | 10 | January 16, 2012 |
| adhesions & ECM | 29 | January 12, 2012 |
| nucleus and gene expression | 22 | January 12, 2012 |
| cytoskeleton | 20 | January 12, 2012 |
| branches of the lumbar and sacral plexuses | 11 | December 5, 2011 |
| lower leg | 13 | December 3, 2011 |
| foot | 17 | December 3, 2011 |
| biochem unit 1 review | 35 | November 30, 2011 |
| heme metabolism | 9 | November 24, 2011 |
| pyrimidine metabolism | 6 | November 24, 2011 |
| purine metabolism | 13 | November 23, 2011 |
| products of AA | 14 | November 23, 2011 |
| micronutrients II | 20 | November 23, 2011 |
| micronutrients I | 20 | November 20, 2011 |
| knee | 11 | November 20, 2011 |
| pelvic vessels and nerves | 22 | November 20, 2011 |
| thigh | 20 | November 20, 2011 |
| AA synthesis | 11 | November 15, 2011 |
| AA catabolism | 24 | November 13, 2011 |
| urea cycle | 7 | November 13, 2011 |
| AA metabolism | 7 | November 13, 2011 |
| posterior abdominal wall | 9 | November 5, 2011 |
| intestines | 7 | November 4, 2011 |
| abdominal viscera | 15 | November 4, 2011 |
| inguinal region | 10 | November 4, 2011 |
| abdomen | 11 | November 4, 2011 |
| GI development | 25 | November 2, 2011 |
| angiogenesis | 15 | November 1, 2011 |
| body cavity devo | 5 | October 30, 2011 |
| ketones & sphingolipids | 15 | October 29, 2011 |
| reverse cholesterol transport | 10 | October 29, 2011 |
| lipoproteins | 27 | October 26, 2011 |
| lipid biosynthesis & regulation | 19 | October 26, 2011 |
| lipid absorption | 22 | October 25, 2011 |
| thoracic cavity | 30 | October 19, 2011 |
| glycogenolysis & glycogenesis | 3 | October 14, 2011 |
| gluconeogenesis | 10 | October 13, 2011 |
| Glycolysis | 23 | October 13, 2011 |
| eye | 15 | October 8, 2011 |
| thyroid, tongue, and face | 13 | October 8, 2011 |
| larynx | 10 | October 6, 2011 |
| oral cavity | 12 | October 6, 2011 |
| ear | 7 | October 6, 2011 |
| nasal cavity | 12 | October 5, 2011 |
| orbit | 5 | October 4, 2011 |
| face | 12 | October 4, 2011 |
| pharyngeal arches | 18 | September 29, 2011 |
| dev. of cerebrum and cerebellum | 23 | September 28, 2011 |
| neuraxis | 35 | September 28, 2011 |
| pharynx | 25 | September 27, 2011 |
| contents of cranial structures | 17 | September 24, 2011 |
| signaling | 35 | September 24, 2011 |
| enzyme regulation | 18 | September 23, 2011 |
| enzyme kinetics | 12 | September 23, 2011 |
| enzyme catalysis | 9 | September 23, 2011 |
| Hb and allosterism | 16 | September 23, 2011 |
| protein stability | 9 | September 23, 2011 |
| tertiary & quaternary structure | 14 | September 22, 2011 |
| primary and secondary protein structure | 13 | September 21, 2011 |
| water & amino acids | 16 | September 21, 2011 |
| neck structures | 27 | September 21, 2011 |
| face structures | 18 | September 19, 2011 |
| Upper extremity nerves | 8 | September 12, 2011 |
| Muscle to nerves | 49 | September 9, 2011 |